XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Comprehensive Income - EUR (€)
€ in Millions
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Statement of comprehensive income [abstract]    
Net income € 5,837 € 2,263 [1]
Attributable to equity holders of Sanofi 5,812 2,246 [2]
Attributable to non-controlling interests 25 17 [2]
Other comprehensive income:    
Actuarial gains/(losses) 111 235 [1]
Change in fair value of equity instruments included in financial assets and financial liabilities 222 (10) [1]
Tax effects (92) (59) [1]
Items not subsequently reclassifiable to profit or loss 241 166 [1]
Change in fair value of debt instruments included in financial assets 3 (5) [1]
Change in fair value of cash flow hedges (23) (3) [1]
Change in currency translation differences (5,203) 1,040 [1]
Tax effects (95) 35 [1]
Items subsequently reclassifiable to profit or loss (5,318) 1,067 [1]
Other comprehensive income from continued operations (5,077) 1,233 [1]
Other comprehensive income from discontinued operations 303 (23) [1]
Comprehensive income 1,063 3,496 [1]
Attributable to equity holders of Sanofi 1,076 3,471 [1]
Comprehensive income, attributable to owners of parent, continuing operations (2,097) 3,264 [1]
Comprehensive income, attributable to owners of parent, discontinued operations 3,173 207 [1]
Attributable to non-controlling interests € (13) € 25 [1]
[1] Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.
[2] Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.